Moderna develops and sells mRNA-based medicines, mainly COVID-19 vaccines, and is developing treatments for cancer and rare diseases. It last closed at $195.00 on Nov 20, down 2.17% on the day. The next earnings report for MRNA is expected around Mon, Jan 11, 2027. For the quarter ended Sep 2026, MRNA reported EPS of $0.38 on revenue of $1.31B, with revenue up 29.2% from a year ago. Over its last 8 reports the stock moved an average of 4.2% the session after earnings. Over the last 12 months MRNA insiders bought $0 of stock on the open market and sold $98.5M, according to SEC Form 4 filings.
AI Auto Pilots
Is MRNA in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold MRNA.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on MRNAStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
MRNA · as of the Nov 20 close · updated each morning
Pullback inside a longer uptrend
The stock is 16% below its 20 day and 7% below its 50 day average. It is 48% above its 200 day average, so the longer trend is still up. Momentum is weak (RSI 41). The nearest support is the Pivot S1 at $187.64, and the nearest resistance the Pivot at $198.82.
Short trendBearish
Long trendBullish
MomentumWeak
StretchNormal
VolatilityNormal, 9.4%/day
Key levels
$280.8052 week high+44.0%
$225.2620 day average+15.5%
$208.90Swing high (Sep 29)+7.1%
$207.8950 day average+6.6%
$206.18Pivot R1+5.7%
$198.82Pivot+2.0%
$195.00Last close
$187.64Pivot S1−3.8%
$182.50Swing low (Oct 7)−6.4%
$149.46100 day average−23.4%
$100.42200 day average−48.5%
$22.2852 week low−88.6%
Indicators
RSI (14)
41.15
Middle of its range
Neutral
MACD
-1.15
Below its signal line
Bearish
Stochastic
5.4
Near the bottom of its range
Oversold
ADX (14)
27.2
Trending down
Williams %R
-94.5
Oversold below −80, overbought above −20
Oversold
CCI (20)
-96.7
Oversold below −100, overbought above 100
Neutral
Rate of change
−23.3%
Change over 10 sessions
Bearish
ATR (14)
$18.42
Typical daily range, 9.4% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Above
MA 200Above
Uptrend
Short trendBullish
Long trendBullish
MomentumStrong
StretchNormal
VolatilityHigh, 16.5%/day
Key levels
$280.8052 week high+44.0%
$225.2620 day average+15.5%
$208.90Swing high (Sep 29)+7.1%
$207.8950 day average+6.6%
$206.18Pivot R1+5.7%
$198.82Pivot+2.0%
$195.00Last close
$187.64Pivot S1−3.8%
$182.50Swing low (Oct 7)−6.4%
$149.46100 day average−23.4%
$100.42200 day average−48.5%
$22.2852 week low−88.6%
Indicators
RSI (14)
60.81
Strong, overbought above 70
Neutral
MACD
42.78
Above its signal line
Bullish
Stochastic
76.3
Middle of its range
Neutral
ADX (14)
60.5
Strong uptrend
Williams %R
-39.2
Oversold below −80, overbought above −20
Neutral
CCI (20)
60.5
Oversold below −100, overbought above 100
Neutral
Rate of change
+35.4%
Change over 10 sessions
Bullish
ATR (14)
$32.12
Typical daily range, 16.5% of price
MA 10Below
MA 20Above
MA 50Above
MA 100Above
MA 200Above
What happened before, for MRNA
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how MRNA did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow MRNA usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for MRNAHow many large options trades hit MRNA, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in MRNA in the last 90 days.
From SEC Form 4 filings by MRNA's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether MRNA is in one of them and how their past MRNA trades turned out.
From official House and Senate disclosure reports, filed up to 45 days after the trade and shown in dollar ranges. Not investment advice. Use limited by 5 U.S.C. 13107. About this data
About Moderna
Moderna is a biotechnology company based in Cambridge, Massachusetts, that develops medicines built on messenger RNA, or mRNA. It has three commercial products, two COVID-19 vaccines and a vaccine against respiratory syncytial virus, which it sells through the U.S. retail channel and through long-term partnerships in the UK, Canada and Australia. The company also develops candidates for cancer, rare diseases and infectious diseases such as flu and norovirus, and it works with partners including Merck and Recordati.